“Vineeta brings with her an impressive background and an array of experience that will be uniquely valuable in leading the Secretariat of the ACTION Global Health Advocacy Partnership. We look forward to working with her in building and strengthening the Partnership and, through it, critical global health outcomes in the world that are urgently needed now and in the final decade toward the global Sustainable Development Goals. We are thrilled to have her onboard.”
After the resounding success of last month’s Global Vaccine Summit, at which more than US $8.8 billion was pledged in support of Gavi, the Vaccine Alliance for the next 5 years, we find ourselves at a pivotal moment for immunisation. These new commitments are meant to enable Gavi to accelerate the roll out of life-saving vaccines in developing countries by 2025 and contribute to saving 8 million more children’s lives. But with COVID-19 currently stifling routine immunisation campaigns, what will it take to ensure that every child is reached with effective vaccines?
"Accelerating Access to Routine Immunization in the Time of COVID-19: What follows Gavi’s replenishment?" An online conversation hosted by Gavi CSO Constituency in partnership with ACTION, Gavi, the Vaccine Alliance, RESULTS UK, and Save the Children.
Washington, DC (June 4) – ACTION Global Health Advocacy Partnership applauds world leaders for significant new financial commitments that will help deliver more than 3.2 billion doses of life-saving vaccines to reach 300 million children by 2025. In the lead up to and during the virtual Global Vaccines Summit, world leaders committed a total of US$8.8 billion in new resources over the next five years to Gavi, a global vaccine alliance bringing together public and private sectors with the shared goal of creating equal access to vaccines for children living in the world's poorest countries. Gavi support has contributed to the immunization of over 760 million children since their inception in 2000, including 198 million children between 2016 and 2018.